Close Menu
NEW YORK (GenomeWeb News) – DNAPrint Genomics today said it and a Spanish biotech will try to identify genes linked to how individuals with ovarian cancer respond to certain chemotherapeutic agents.
 
Terms of the deal call for DNAPrint to test DNA samples collected by NeoCodex of Seville to study “the effectiveness of certain treatments for ovarian cancer” involving Taxotere, Taxol, Carboplatin, and Cisplatin.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.